Delivery Order SPE2DB22D2006-SPE2DB24FW1MR

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,632.64 and is a Firm Fixed Price Delivery Order for the supply of RYANODEX 250 MG VIALS. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The $2,979.28 firm-fixed-price contract has a completion date of July 11, 2024. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $53,627.04 Firm Fixed Price Delivery Order contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of August 5, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $9,632.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, to support federal healthcare programs. The contract has a completion date of January 30, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Ryanodex 250 mg vials. The $1,489.64 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $5,958.56, is for the delivery of RYANODEX 250 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. No set-aside designation was used for this award....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a ceiling value of $4,816.32 and a period of performance through March 14, 2025. This is a firm-fixed-price delivery order contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a potential value of $2,979.28 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 250 mg Ryanodex vials. The contract has a ceiling value of $4,468.92 and an ultimate completion date of August 14, 2024. It is a delivery order contract with a firm fixed-price pricing type. This award is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office Division is the...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1MR
    Delivery Order

This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, awarded to AmerisourceBergen Drug Corp's Corporate Office Division, has a ceiling value of $5,958.56 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation.

AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to DLA facilities supporting the DoD worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/30/24, 4:59 PM